Idaho Falls Community Hospital LLC
Idaho Falls Community Hospital LLC was paid $540K by Medicaid between Dec 2019 and Dec 2024, across 78 billing codes. Its largest line is 99284, emergency room visit (serious) — 25% of everything it billed.
IDAHO FALLS, ID 83404
Next to other General Acute Care Hospital providers in Idaho
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 160 | $900.44 | |
| 2020 | 10,202 | $151K | |
| 2021 | 4,634 | $51K | |
| 2022 | 5,145 | $59K | |
| 2023 | 5,575 | $116K | |
| 2024incomplete | 4,348 | $162K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 1,579 | 1,350 | $137K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 13% | 486 | 486 | $68K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 11% | 179 | 176 | $61K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.8% | 505 | 425 | $53K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.8% | 410 | 407 | $42K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.1% | 976 | 831 | $33K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.5% | 166 | 163 | $24K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 4.1% | 130 | 130 | $22K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.9% | 159 | 151 | $16K |
| 80053 | Comprehensive metabolic panel | 1.7% | 3,363 | 2,625 | $9K |
| 99205 | Prolong outpt/office vis | 1.2% | 37 | 37 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,859 | 2,270 | $5K |
66 more codes
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 132 | $5K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 172 | $5K |
| 87486 | <1% | 157 | $4K | |
| 87581 | <1% | 157 | $4K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 247 | $3K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 27 | $3K |
| 86140 | <1% | 2,122 | $3K | |
| 82805 | <1% | 256 | $3K | |
| 86710 | <1% | 94 | $3K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 878 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 550 | $2K |
| 81001 | <1% | 1,880 | $2K | |
| 84484 | <1% | 736 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,066 | $2K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 25 | $2K |
| 83690 | <1% | 448 | $1K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 20 | $1K |
| 81025 | <1% | 198 | $1K | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 155 | $1K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,350 | $1K |
| J3486 | Injection, ziprasidone mesylate, 10 mg | <1% | 32 | $1K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 18 | $1K |
| 85027 | <1% | 389 | $1K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 176 | $1K |
| 93000 | <1% | 99 | $1K | |
| 87430 | <1% | 61 | $812.61 | |
| 80305 | <1% | 78 | $752.30 | |
| 85378 | <1% | 113 | $602.42 | |
| 85007 | <1% | 344 | $598.24 | |
| 87040 | <1% | 27 | $421.22 | |
| 83735 | <1% | 260 | $416.33 | |
| 83880 | <1% | 13 | $377.10 | |
| 82948 | <1% | 65 | $370.72 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 610 | $370.12 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 80 | $367.35 |
| 87081 | <1% | 55 | $358.48 | |
| 72100 | <1% | 25 | $343.70 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 962 | $300.68 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 169 | $272.65 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 943 | $247.59 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,531 | $237.65 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 33 | $235.07 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 116 | $205.98 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 14 | $205.48 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,067 | $197.07 |
| 73030 | <1% | 13 | $146.16 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 84 | $139.87 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 16 | $107.80 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 255 | $102.07 |
| 84439 | <1% | 12 | $90.18 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 62 | $87.34 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 129 | $52.01 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 49 | $35.33 |
| J2704 | Injection, propofol, 10 mg | <1% | 13 | $33.33 |
| 85610 | <1% | 15 | $30.63 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 31 | $16.33 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 18 | $9.29 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 137 | $7.06 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 51 | $4.70 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 17 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 21 | $0.00 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 17 | $0.00 |
| 80320 | 0% | 14 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 166 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 56 | $0.00 |
| A9270 | Non-covered item or service | 0% | 89 | $-79.89 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| MVH BMC LLC | Blackfoot, ID | $11.61M |
| MVH Pic LLC | Pocatello, ID | $3.03M |
| Mountain View Hospital LLC | Pocatello, ID | $1.72M |
| MVH BMC LLC | Shelley, ID | $1.08M |
| Idaho Falls Asc | Idaho Falls, ID | $386K |
| Prescription Center Home Care, LLC | Idaho Falls, ID | $244K |
| MVH PC Specialists LLC | Pocatello, ID | $168K |
| MVH Parkway LLC | Blackfoot, ID | $126K |
| MV Pocatello Ent, LLC | Pocatello, ID | $118K |
| Snake River Hospitalists, LLC | Idaho Falls, ID | $55K |
| MVH PMHS LLC | Pocatello, ID | $52K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.